|
|
| TH-SC01 / Topcel-KH Pharma (0 Trials) |
|
| Th17 cell inhibitor / Merck (MSD) (0 Trials) |
|
| TH1901 / Theratechnologies (0 Trials) |
|
| THAL-SNS-032 / Dana-Farber Cancer Institute (0 Trials) |
|
| Thalagen (autologous CD34+ cells transduced with TNS9.3.55) / San Rocco Therap, Memorial Sloan-Kettering Cancer Center (0 Trials) |
|
| thalidomide / Generic mfg. (129 Trials) |
|
| thalidomide inhalation (VP02) / Vicore Pharma (0 Trials) |
|
| thapsigargin / University of Nottingham, Pirbright Institute (0 Trials) |
|
| THB001 / Third Harmonic Bio (0 Trials) |
|
| THBAZ / Eli Lilly (0 Trials) |
|
| THC-valine-hemisuccinate (SBI-100) / Skye Biosci (0 Trials) |
|
| THE-349 / Concentra Biosci (0 Trials) |
|
| THE-630 / Concentra Biosci (0 Trials) |
|
| theliatinib (HMPL-309) / Hutchmed (0 Trials) |
|
| Thelin (oral sitaxsentan) / Pfizer (0 Trials) |
|
| THEO-260 / Theolytics (0 Trials) |
|
| THEO-310 / Theolytics (0 Trials) |
|
| theophylline (ADC-4022) / Pulmagen Therap (1 Trials) |
|
| theophylline extended-release / Generic mfg. (0 Trials) |
|
| theophylline sodium glycinate / Generic mfg. (0 Trials) |
|
| TheraCIM (nimotuzumab) / Daiichi Sankyo, Oncoscience, Biocon (107 Trials) |
|
| Theracurmin (curcumin) / Handok (0 Trials) |
|
| TheraCys (PMCJ-9) / Sanofi (4 Trials) |
|
| Theradux (recombinant modified human thioredoxin 1) / OrPro Therap (0 Trials) |
|
| theralizumab (TAB08) / TheraMab (0 Trials) |
|
| Therapeutic Enzymes / PHAXIAM Therap (0 Trials) |
|
| therapeutic HBV vaccine / GeneCure Biotechnologies (0 Trials) |
|
| therapeutic interfering particles (TIP) / Gladstone Institute (0 Trials) |
|
| TheraPhil / University of Queensland (0 Trials) |
|
| TheraSeed (palladium-103) / Theragenics (8 Trials) |
|
| TheraSphere (yttrium 90 microspheres) / Boston Scientific (20 Trials) |
|
| Theravac (docusate) / Institut Pasteur (0 Trials) |
|
| ThermoDox (lyso-thermosensitive liposomal doxorubicin) / Imunon (2 Trials) |
|
| ThermoDox + HIFU / Imunon (3 Trials) |
|
| ThermoProfen (matrix Transdermal Ketoprofen) / Miravo (0 Trials) |
|
| TherVacB / German Center for Infection Research, German Research Center for Environmental Health, Technical University of Munich (0 Trials) |
|
| Thetanix (bacteroides thetaiotaomicron) / CJ Biosci (0 Trials) |
|
| thiarabine (4-thio Ara-C) / Abeona Therap (1 Trials) |
|
| thienotriazolodiazepine (RO 111464) / Roche, Novartis (0 Trials) |
|
| thiethylperazine / Immungenetics (0 Trials) |
|
| thimerosal (BTL-TML) / Beech Tree Labs (0 Trials) |
|
| thiocolchicoside / Generic mfg. (2 Trials) |
|
| thiocolchicoside/aceclofenac/paracetamol / Generic mfg. (0 Trials) |
|
| thioguanine / Generic mfg. (43 Trials) |
|
| Thiolanox (nitric oxide) / Novoteris (3 Trials) |
|
| thiopyrano quinoline (MT477) / Medisyn Technologies (0 Trials) |
|
| thioridazine / Generic mfg. (0 Trials) |
|
| thiostrepton (RSO-021) / RS Oncology (0 Trials) |
|
| thiotepa / Generic mfg. (79 Trials) |
|
| thiothixene / Generic mfg. (0 Trials) |
|
| ThisCART19A / Fundamenta Therap (0 Trials) |
|
| ThisCART22 / Fundamenta Therap (0 Trials) |
|
| ThisCART7 / Fundamenta Therap (0 Trials) |
|
| THOR-908 / Sanofi (0 Trials) |
|
| THOR-918 / Sanofi (0 Trials) |
|
| THOR-924 / Sanofi (0 Trials) |
|
| Thorinane (enoxaparin biosimilar) / Pharmathen (0 Trials) |
|
| thorium (227Th) anetumab corixetan (BAY 2287411) / Bayer (0 Trials) |
|
| THR-0921 / TheracosBio, Egret (0 Trials) |
|
| THR-149 / Oxurion (0 Trials) |
|
| THR-18 / D-Pharm (0 Trials) |
|
| THR-184 / Thrasos Therap (0 Trials) |
|
| THR-687 / Oxurion (0 Trials) |
|
| Thravixa (AVP-21D9) / Emergent Biosolutions (0 Trials) |
|
| three-dose rabies vaccine / Novavax (0 Trials) |
|
| threitolceramide 6 liposomal (PORT-2) / Portage (0 Trials) |
|
| Thrombate III (antithrombin III human) / Grifols (0 Trials) |
|
| Thrombin kaketsuken (thrombin) / Meiji Seika (0 Trials) |
|
| Thromboreductin (anagrelide hydrocloride) / AOP Orphan Pharma (0 Trials) |
|
| thrombospondin-1 mimetic (ABT-510) / AbbVie (1 Trials) |
|
| THRYV-1257 / Thryv Therap (0 Trials) |
|
| THV-01 / TheraVectys (0 Trials) |
|
| THX-150 / SciSparc (0 Trials) |
|
| Thykamine (PUR 0110) / Devonian Health Group (0 Trials) |
|
| Thymitaq (nolatrexed) / Gilead (0 Trials) |
|
| Thymoglobulin (anti-thymocyte globulin (rabbit)) / Sanofi (108 Trials) |
|
| thyroxine / Generic mfg. (59 Trials) |
|
| TI-002 / Trigemina (0 Trials) |
|
| Ti-061 / Arch Oncology (0 Trials) |
|
| TI-1001 / Timmune Biotech (0 Trials) |
|
| TI-1007 / Timmune Biotech, Shenzhen Beike Biotech (0 Trials) |
|
| TI-168 / Baudax Bio (0 Trials) |
|
| TI-299423 / Catalyst Biosci (0 Trials) |
|
| TI-495 / Optipharm, Baudax Bio (0 Trials) |
|
| TIA / Tallac Therap (0 Trials) |
|
| tianeptine / Generic mfg. (6 Trials) |
|
| tianeptine hemioxalate extended-release (TNX-601 ER) / Tonix (0 Trials) |
|
| tianeptine oxalate controlled release (TNX-601 CR) / Tonix (0 Trials) |
|
| tiapamil (ORE5002) / Ore Holdings (0 Trials) |
|
| Tibsovo (ivosidenib) / Servier (34 Trials) |
|
| tibulizumab (ZB-106) / Zura Bio (0 Trials) |
|
| ticagrelor / Generic mfg. (171 Trials) |
|
| Tice BCG (live attenuated bacillus Calmette-Guerin) / Merck (MSD), Texas A&M University (11 Trials) |
|
| TicoVac (tick-borne encephalitis vaccine, whole Virus inactivated) / Pfizer (0 Trials) |
|
| TIDAL-01 / Turnstone Biologics (0 Trials) |
|
| tidutamab (XmAb18087) / Xencor (2 Trials) |
|
| tifcemalimab (TAB004) / Shanghai Junshi Biosci (6 Trials) |
|
| tigatuzumab (CS-1008) / Daiichi Sankyo (0 Trials) |
|
| tigecycline / Generic mfg. (42 Trials) |
|
| Tigeraze (dornase alfa biosimilar) / Generium (0 Trials) |
|
| tigilanol tiglate (EBC-46) / Qbiotics (0 Trials) |
|
| TIGIT-Fc-OX40L / Shattuck (0 Trials) |
|
| tigozertinib (BLU-945) / Blueprint Medicines (0 Trials) |
|
| tigulixostat (LC350189) / LG Chem (0 Trials) |
|
| tilarginine (L-NMMA) / Arginox Pharma, Houston Methodist Research Institute (0 Trials) |
|
| tilatamig samrotecan (AZD9592) / AstraZeneca (0 Trials) |
|
| tilavonemab (ABBV-8E12) / AbbVie (2 Trials) |
|
| tildacerfont (SPR001) / Spruce Biosciences, Kaken Pharma (0 Trials) |
|
| tilidine / Aoxing (0 Trials) |
|
| tilpisertib (GS-4875) / Gilead (0 Trials) |
|
| tilpisertib fosmecarbil (GS-5290) / Gilead (0 Trials) |
|
| tilsotolimod (IMO-2125) / Idera (3 Trials) |
|
| tilvestamab (BGB149) / BerGenBio (0 Trials) |
|
| TIM-3 antibody / Cellerant Therap (0 Trials) |
|
| TIM-3 inhibitor / Partikula (0 Trials) |
|
| Tim-3 modulator mAb / Ligand (0 Trials) |
|
| timapiprant (OC000459) / Chiesi (0 Trials) |
|
| timbetasin intravenous (RGN-352) / RegeneRx (0 Trials) |
|
| timbetasin ophthalmic (RGN-259) / ReGenTree (1 Trials) |
|
| timbetasin topical (RGN-137) / RegeneRx (0 Trials) |
|
| Timcynis (ticarcillin and clavulanic acid) / Emcure (0 Trials) |
|
| Timodine (nystatin, dimeticone 350, hydrocortisone & benzalkonium chloride) / Alliance (0 Trials) |
|
| timolol maleate ophthalmic solution / Generic mfg. (36 Trials) |
|
| timolol oral / Generic mfg. (0 Trials) |
|
| timolumab (BTT1023) / Acorda (0 Trials) |
|
| Timozin (tiemonium methyl sulphate) / Incepta Pharma (0 Trials) |
|
| timrepigene emparvovec (BIIB111) / Biogen (2 Trials) |
|
| timtraxanib (AVI-3207) / Avixgen (0 Trials) |
|
| TIN816 / Novartis (0 Trials) |
|
| TinaGrast (filgrastim biosimilar) / AryoGen Pharmed (0 Trials) |
|
| Tinefcon (NPS31807) / Piramal Phytocare (0 Trials) |
|
| tinengotinib (TT-00420) / TransThera Biosci (0 Trials) |
|
| Tinirem (tinidazole) / Remedica (0 Trials) |
|
| tinlarebant (BPN-14967) / Lin BioSci (0 Trials) |
|
| tinlorafenib (PF-07284890) / Pfizer (0 Trials) |
|
| Tinobac (spectinomycin) / Incepta Pharma (0 Trials) |
|
| tinostamustine (EDO-S101) / Mundipharma (0 Trials) |
|
| tinurilimab (BAY1834942) / Bayer (0 Trials) |
|
| Tiorfan (racecadotril) / Bioprojet (6 Trials) |
|
| tiotropium bromide dry powder inhaler / Generic mfg. (0 Trials) |
|
| tiotropium bromide inhalation (CXF11) / Chance Pharma (0 Trials) |
|
| tiotropium bromide inhalation (VR410) / Pulmatrix (0 Trials) |
|
| tiotropium bromide solution (GSP-304) / Glenmark (0 Trials) |
|
| tipapkinogene sovacivec (TG4001) / European Organization for Research and Treatment of Cancer, Transgene (1 Trials) |
|
| tipelukast (MN-001) / MediciNova (1 Trials) |
|
| tiprelestat (SKALP) / tiakis Biotech (2 Trials) |
|
| tiragolumab (RG6058) / Roche (26 Trials) |
|
| tirasemtiv (CK-2017357) / Astellas, Cytokinetics (0 Trials) |
|
| Tirazone (tirapazamine) / Teclison, SRI International (0 Trials) |
|
| tirbanibulin oral (KX2-391 oral) / Hanmi, Athenex (1 Trials) |
|
| TISQ / Eli Lilly (0 Trials) |
|
| Titragesia (fentanyl transdermal) / Miravo (0 Trials) |
|
| tivanisiran (SYL1001) / PharmaMar (1 Trials) |
|
| tivantinib (ARQ 197) / Daiichi Sankyo, Kyowa Kirin, Merck (MSD) (2 Trials) |
|
| Tivdak (tisotumab vedotin-tftv) / Genmab, Pfizer (3 Trials) |
|
| Tivicay (dolutegravir) / ViiV Healthcare (61 Trials) |
|
| Tivorbex (nanotechnology formulated indomethacin) / Iroko (0 Trials) |
|
| tivozanib eye drops (KHK4951) / Kyowa Kirin (0 Trials) |
|
| tivozanib ocular form / Astellas (0 Trials) |
|
| tivumecirnon (FLX475) / RAPT Therap, Hanmi (0 Trials) |
|
| tizanidine / Generic mfg. (17 Trials) |
|
| tizanidine 3-6 M (DLP-208) / Delpor (0 Trials) |
|
| Tizaspray (tizanidine nasal spray) / Neopharmed (0 Trials) |
|
| tizaterkib (ATG-017) / Antengene (0 Trials) |
|
| TJ-C4GM / I-Mab (0 Trials) |
|
| TJ-C64B / I-Mab (0 Trials) |
|
| TJ-L1C4 / I-Mab (0 Trials) |
|
| TJ-L1D5 / I-Mab (0 Trials) |
|
| TJ-L1H3 / I-Mab (0 Trials) |
|
| TJ-L1I7 / I-Mab (0 Trials) |
|
| TJ-L1IF / I-Mab (0 Trials) |
|
| TJA3 / I-Mab (0 Trials) |
|
| TJC-265 / TaiwanJ (0 Trials) |
|
| TJC0316 / TaiwanJ (0 Trials) |
|
| TJC0434 / TaiwanJ (0 Trials) |
|
| TJC4-CK / I-Mab (0 Trials) |
|
| TJT6 / I-Mab (0 Trials) |
|
| tk RNAi / Adhera Therap (0 Trials) |
|
| TK-2504 / T-knife Therap (0 Trials) |
|
| TK-8001 / T-knife Therap (0 Trials) |
|
| TK-kRAS / Tosk (0 Trials) |
|
| TKM-ALDH / Arbutus (0 Trials) |
|
| TKM-ALDH2 / Arbutus (0 Trials) |
|
| TKM-Ebola / Arbutus (0 Trials) |
|
| TKM-Ebola-Guinea / Arbutus (0 Trials) |
|
| TKM-HTG / Arbutus (0 Trials) |
|
| TKM-Marburg / Arbutus (0 Trials) |
|
| TKM-PLK1 / Arbutus (0 Trials) |
|
| TL-01 / Merck (MSD) (0 Trials) |
|
| TL-02 / Merck (MSD) (0 Trials) |
|
| TL-03 / Merck (MSD) (0 Trials) |
|
| TL-04 / Merck (MSD) (0 Trials) |
|
| TL-05 / Merck (MSD) (0 Trials) |
|
| TL-1-85 / Massachusetts General Hospital, Wellcome Sanger Institute (0 Trials) |
|
| TL-532 / Tollys (0 Trials) |
|
| TL011 (rituximab biosimilar) / Teva (0 Trials) |
|
| TL117 / Suzhou Junde Biotechnology (0 Trials) |
|
| Tlando (testosterone undecanoate) / Lipocine (0 Trials) |
|
| Tlando XR (testosterone ester prodrug) / Lipocine (0 Trials) |
|
| TLC-2716 / OrsoBio (0 Trials) |
|
|